skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
17597957
Filing Dt:
01/31/2022
Publication #:
Pub Dt:
08/18/2022
Inventors:
Peter BLENCOWE, Mark CHARLES, Tennyson EKWURU, Harry FINCH, Hollie MCCARRON, Robert HEALD et al
Title:
DEUTERATED COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
Assignment: 1
Reel/Frame:
060050/0677Recorded: 05/31/2022Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
10/21/2021
Assignee:
BABRAHAM RESEARCH CAMPUS
BABRAHAM HALL
CAMBRIDGE, UNITED KINGDOM CB22 3AT
Correspondent:
HARRY J. GUTTMAN
2200 PENNSYLVANIA AVE., NW
4TH FLOOR EAST
WASHINGTON, DC 20037
Assignment: 2
Reel/Frame:
060045/0680Recorded: 05/29/2022Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
10/22/2021
Exec Dt:
11/05/2021
Exec Dt:
10/25/2021
Exec Dt:
11/05/2021
Assignee:
2 REDMAN PLACE
LONDON, UNITED KINGDOM E20 1JQ
Correspondent:
HARRY J. GUTTMAN
2200 PENNSYLVANIA AVE., NW
4TH FLOOR EAST
WASHINGTON, DC 20037
Assignment: 3
Reel/Frame:
060045/0672Recorded: 05/29/2022Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
11/19/2021
Exec Dt:
11/13/2021
Exec Dt:
11/16/2021
Assignee:
BABRAHAM RESEARCH CAMPUS
BABRAHAM HALL
CAMBRIDGE, UNITED KINGDOM CB22 3AT
Correspondent:
HARRY J. GUTTMAN
2200 PENNSYLVANIA AVE., NW
4TH FLOOR EAST
WASHINGTON, DC 20037

Search Results as of: 05/13/2024 03:12 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT